株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖値計:パイプライン分析

Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 328675
出版日 ページ情報 英文 481 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.99円で換算しております。
Back to Top
血糖値計:パイプライン分析 Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017
出版日: 2017年04月04日 ページ情報: 英文 481 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の血糖値計のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の開発・資本取引の動きなどを盛り込んでお届けいたします。

目次

  • イントロダクション
    • 血糖値計の概略
  • 開発中の製品
    • パイプライン製品:開発段階別
    • パイプライン製品:セグメント別
    • パイプライン製品:地域別
    • パイプライン製品:規制経路別
    • パイプライン製品:認証時期 (推定) 別
    • パイプライン製品:進行中の治験
  • 血糖値計:開発中のパイプライン製品 (企業別)
    • 血糖値計の開発企業:パイプライン製品 (開発段階別)
    • 血糖値計:開発段階別のパイプライン製品
  • 血糖値計の開発企業・製品の概要
  • 4a Medicom GmbH
    • パイプライン製品/進行中の治験の概要
  • A*STAR Institute of Microelectronics
  • A. Menarini Diagnostics S.r.l.
  • Abbott Diabetes Care, Inc.
  • Advanced Biosensors-Ohio, Llc
  • Advanced Medical Electronics Corporation
  • AirMarkers
  • Alcon, Inc.
  • Arkal Medical, Inc.
  • Azurite Technologies, Inc.
  • Bar-Ilan University
  • Baylor University
  • Biorasis, Inc.
  • BioTex, Inc.
  • Biovotion AG
  • BlueVine Graphene Industries, Inc.
  • C8 MediSensors, Inc.
  • Capillary Biomedical, Inc.
  • Cardiff University
  • Cascade Metrix, Inc.
  • CGM3 Ltd
  • Cnoga Medical Ltd.
  • ConvaTec Healthcare B S.a.r.l.
  • DexCom, Inc.
  • DIRAmed LLC.
  • Echo Therapeutics, Inc.
  • Elte Sensoric GmbH
  • eLutions Integrated Systems, Inc.
  • EyeSense GmbH
  • Flowsion AS
  • Freedom Meditech, Inc.
  • Gili Medical Ltd
  • Globe Medical Tech, Inc.
  • Glucometrics, Inc.
  • Glucometrix AG
  • Glucosense Diagnostics, Ltd.
  • GlucoSet AS
  • Glucovation, Inc.
  • GluMetrics, Inc.
  • GluSense Ltd.
  • GlySens Incorporated
  • GlySure Ltd
  • Grove Instruments Inc.
  • Hygiena, LLC
  • Hypo-Safe A/S
  • Institute of Biomedical Engineering (ISIB-CNR)
  • Insulet Corporation
  • Integrity Applications Ltd.
  • Intuity Medical, Inc.
  • Invivomon Inc.
  • LabStyle Innovations Corp.
  • Lein Applied Diagnostics Limited
  • LEMM Technologies, LLC
  • LifeScan, Inc.
  • LighTouch Medical, Inc.
  • Maquet Holding B.V. & Co. KG.
  • Massachusetts Institute of Technology
  • MASTInc
  • Medella Health Inc.
  • Medical Wireless Sensing Ltd
  • Medtronic plc
  • Mellitor Ltd.
  • Mendor Oy
  • MicroCHIPS, Inc.
  • mobiLIFE
  • 長崎大学
  • Nemaura Medical Inc
  • Newton Photonics Inc
  • Northwestern University
  • NovioSense B.V.
  • Optiscan Biomedical Corporation
  • Pepex Biomedical, Inc.
  • Pignolo SpA
  • PositiveID Corporation
  • Quick, LLC
  • Senseonics, Incorporated
  • Sentec AG
  • Senzime AB
  • Socrates Health Solutions, Inc.
  • St. Louis Medical Devices, Inc
  • Tandem Diabetes Care, Inc.
  • TecMed, Inc.
  • テルモ
  • The Charles Stark Draper Laboratory Inc
  • The University of Bari Aldo Moro
  • Ultradian Diagnostics LLC
  • University of Bath
  • University of Calgary
  • University of California, Berkeley
  • University of California, San Diego
  • University of South Florida
  • University of Western Ontario
  • Vytrace, Inc.
  • Xhale, Inc.
  • 昨今の動向 (計104件)
  • 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017" provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Blood Glucose Meters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Blood Glucose Meters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 11
  • 1.2 List of Figures 20

2 Introduction 21

  • 2.1 Blood Glucose Meters Overview 21

3 Products under Development 22

  • 3.1 Blood Glucose Meters - Pipeline Products by Stage of Development 22
  • 3.2 Blood Glucose Meters - Pipeline Products by Segment 23
  • 3.3 Blood Glucose Meters - Pipeline Products by Territory 24
  • 3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path 26
  • 3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date 27
  • 3.6 Blood Glucose Meters - Ongoing Clinical Trials 28

4 Blood Glucose Meters - Pipeline Products under Development by Companies 29

  • 4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development 29
  • 4.2 Blood Glucose Meters - Pipeline Products by Stage of Development 34

5 Blood Glucose Meters Companies and Product Overview 39

  • 5.1 4a Medicom GmbH Company Overview 39
  • 5.2 A. Menarini Diagnostics S.r.l. Company Overview 40
  • 5.3 Abbott Diabetes Care, Inc. Company Overview 41
  • 5.4 Advanced Biosensors-Ohio, Llc Company Overview 47
  • 5.5 Advanced Medical Electronics Corporation Company Overview 48
  • 5.6 AirMarkers Company Overview 49
  • 5.7 Animas Corp Company Overview 50
  • 5.8 Arkal Medical, Inc. Company Overview 52
  • 5.9 Arkray Inc Company Overview 53
  • 5.10 Ascensia Diabetes Care Holdings AG Company Overview 54
  • 5.11 Azurite Technologies, Inc. Company Overview 56
  • 5.12 Bar-Ilan University Company Overview 57
  • 5.13 Baylor University Company Overview 58
  • 5.14 Bio-Impedance General Ltd. Company Overview 59
  • 5.15 Biopeak Corp Company Overview 60
  • 5.16 Biorasis, Inc. Company Overview 61
  • 5.17 BioTelemetry Inc Company Overview 62
  • 5.18 BioTex Inc Company Overview 63
  • 5.19 Biovotion AG Company Overview 64
  • 5.20 BlueVine Graphene Industries, Inc. Company Overview 66
  • 5.21 Brigham and Women's Hospital Company Overview 68
  • 5.22 CALISTO MEDICAL, INC. (Inactive) Company Overview 69
  • 5.23 Cardiff University Company Overview 70
  • 5.24 Cell MedX Corp Company Overview 71
  • 5.25 CGM3 Ltd Company Overview 74
  • 5.26 City, University of London Company Overview 75
  • 5.27 Columbia University Company Overview 76
  • 5.28 ConvaTec Group Plc Company Overview 77
  • 5.29 Cyber Medical Ltd. Company Overview 78
  • 5.30 DarioHealth Corp Company Overview 79
  • 5.31 Debiotech SA Company Overview 81
  • 5.32 DexCom Inc Company Overview 82
  • 5.33 DiaMonTech GmbH Company Overview 87
  • 5.34 DIRAmed LLC. Company Overview 89
  • 5.35 DirectSens GmbH Company Overview 91
  • 5.36 Echo Therapeutics Inc Company Overview 92
  • 5.37 Ecole Polytechnique Federale de Lausanne Company Overview 95
  • 5.38 eLutions Integrated Systems, Inc. Company Overview 96
  • 5.39 Emperra GmbH E-Health Technologies Company Overview 97
  • 5.40 EyeSense GmbH Company Overview 98
  • 5.41 Flowsion A/S Company Overview 102
  • 5.42 Gili Medical Ltd Company Overview 103
  • 5.43 Globe Medical Tech Inc Company Overview 104
  • 5.44 GlucoLight Corporation (Inactive) Company Overview 105
  • 5.45 GlucoMe Ltd Company Overview 106
  • 5.46 Glucometrix AG Company Overview 109
  • 5.47 Glucosat Company Overview 110
  • 5.48 Glucosense Diagnostics Ltd Company Overview 111
  • 5.49 GlucoSet AS Company Overview 113
  • 5.50 GlucoStats System Pte Ltd. Company Overview 114
  • 5.51 Glucovation Inc Company Overview 116
  • 5.52 GluMetrics Inc Company Overview 117
  • 5.53 GlySens Inc Company Overview 118
  • 5.54 GlySure Ltd Company Overview 122
  • 5.55 Grove Instruments Inc. (Inactive) Company Overview 125
  • 5.56 G-Sense Ltd. Company Overview 127
  • 5.57 Guided Therapeutics Inc Company Overview 128
  • 5.58 i360medical Limited Company Overview 129
  • 5.59 iGlyko, Inc. Company Overview 130
  • 5.60 Indigo Diabetes NV Company Overview 131
  • 5.61 InLight Solutions Inc. Company Overview 132
  • 5.62 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview 133
  • 5.63 Insulet Corp Company Overview 134
  • 5.64 Integrated Medical Group of Irvine Company Overview 135
  • 5.65 Integrity Applications Ltd Company Overview 136
  • 5.66 IntelliDx Inc Company Overview 141
  • 5.67 Intuity Medical Inc Company Overview 142
  • 5.68 Invivomon Inc (Inactive) Company Overview 143
  • 5.69 Invivosense ASA (Inactive) Company Overview 144
  • 5.70 iSense Corporation (Inactive) Company Overview 145
  • 5.71 iXensor Co. Ltd. Company Overview 146
  • 5.72 KeenCAT Technologies Company Overview 147
  • 5.73 Lein Applied Diagnostics Limited Company Overview 148
  • 5.74 LEMM Technologies, LLC Company Overview 149
  • 5.75 LifeScan Inc Company Overview 150
  • 5.76 LighTouch Medical, Inc. Company Overview 151
  • 5.77 Luminous Medical Inc Company Overview 154
  • 5.78 Lyte Labs Company Overview 155
  • 5.79 M Pharmaceutical Inc Company Overview 156
  • 5.80 Massachusetts Institute of Technology Company Overview 157
  • 5.81 MASTInc Company Overview 159
  • 5.82 Medella Health Inc. Company Overview 160
  • 5.83 Medical Wireless Sensing Ltd Company Overview 161
  • 5.84 Medtronic plc Company Overview 162
  • 5.85 Mellitor Ltd. Company Overview 172
  • 5.86 Microchips Biotech Inc Company Overview 173
  • 5.87 MIT Spectroscopy Lab Company Overview 174
  • 5.88 mobiLIFE Company Overview 175
  • 5.89 Nagasaki University Company Overview 176
  • 5.90 Nemaura Medical Inc Company Overview 177
  • 5.91 Newton Photonics Inc Company Overview 179
  • 5.92 NIR Diagnostics Inc. (Inactive) Company Overview 180
  • 5.93 Northwestern University Company Overview 181
  • 5.94 NovioSense BV Company Overview 182
  • 5.95 Optiscan Biomedical Corp Company Overview 183
  • 5.96 Pelikan Technologies, Inc. (Inactive) Company Overview 188
  • 5.97 Pepex Biomedical, Inc. Company Overview 189
  • 5.98 Pignolo SpA Company Overview 190
  • 5.99 Pop Test LLC Company Overview 191
  • 5.100 POPS! Diabetes Care Inc Company Overview 192
  • 5.101 PositiveID Corp Company Overview 194
  • 5.102 Prediktor AS Company Overview 196
  • 5.103 Profusa, Inc. Company Overview 199
  • 5.104 Purdue University Company Overview 200
  • 5.105 Q Step Technologies, Inc. Company Overview 201
  • 5.106 Roche Diabetes Care Inc Company Overview 202
  • 5.107 Royal Adelaide Hospital SA Company Overview 204
  • 5.108 RSP Systems A/S Company Overview 205
  • 5.109 San Meditech (Huzhou) Co., Ltd. Company Overview 206
  • 5.110 Senseonics, Incorporated Company Overview 207
  • 5.111 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 210
  • 5.112 Sensys Medical, Inc. Company Overview 211
  • 5.113 Sentec Pte Ltd Company Overview 212
  • 5.114 Sentek Group, Inc. Company Overview 213
  • 5.115 Senzime AB Company Overview 214
  • 5.116 Shield Diagnostics Company Overview 216
  • 5.117 Singapore Biomicro Pte Ltd Company Overview 217
  • 5.118 Socrates Health Solutions, Inc. Company Overview 218
  • 5.119 Spire Corporation Company Overview 219
  • 5.120 St. Louis Medical Devices, Inc Company Overview 220
  • 5.121 TecMed, Inc. Company Overview 221
  • 5.122 Tenax Therapeutics Inc Company Overview 222
  • 5.123 Terumo Corp Company Overview 223
  • 5.124 Texas A&M University Company Overview 225
  • 5.125 Ultradian Diagnostics LLC Company Overview 226
  • 5.126 University of Bath Company Overview 227
  • 5.127 University of California Berkeley Company Overview 228
  • 5.128 University of California Irvine Company Overview 230
  • 5.129 University of California San Diego Company Overview 231
  • 5.130 University of Central Florida Company Overview 232
  • 5.131 University of Oxford Company Overview 233
  • 5.132 University of South Florida Company Overview 234
  • 5.133 University of Texas at Arlington Company Overview 235
  • 5.134 Vytrace, Inc. Company Overview 236
  • 5.135 Zyvex Corporation Company Overview 237

6 Blood Glucose Meters- Recent Developments 238

  • 6.1 Mar 29, 2017: ConvaTec Group: Directorate changes 238
  • 6.2 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 238
  • 6.3 Mar 28, 2017: ConvaTec: Proposed Directorate Changes 239
  • 6.4 Mar 27, 2017: DarioHealth Launches Insurance Coverage Option for U.S. Consumers 240
  • 6.5 Mar 27, 2017: Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman 240
  • 6.6 Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy 241
  • 6.7 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 242
  • 6.8 Mar 22, 2017: DarioHealth Reports Fourth Quarter and Year End 2016 Results 242
  • 6.9 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion 244
  • 6.10 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million 244
  • 6.11 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million 245
  • 6.12 Mar 21, 2017: Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update 246
  • 6.13 Mar 20, 2017: EKF Diagnostics Holdings: Final results 247
  • 6.14 Mar 14, 2017: PositiveID's E-N-G Mobile Systems' 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter 247
  • 6.15 Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 248
  • 6.16 Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 248
  • 6.17 Mar 02, 2017: EPS Bio Technology Raises USD1.9 Million in IPO 250
  • 6.18 Mar 02, 2017: Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 251
  • 6.19 Mar 02, 2017: DarioHealth Strengthens Board of Directors with Two Additional Appointments 251
  • 6.20 Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 252
  • 6.21 Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 253
  • 6.22 Feb 23, 2017: Henry Schein Launches Newly Designed Website For A Greater Customer Experience 254
  • 6.23 Feb 22, 2017: Another record year for Bayer - good progress with the acquisition of Monsanto 255
  • 6.24 Feb 22, 2017: Change in the B. Braun Management Board 259
  • 6.25 Feb 21, 2017: Henry Schein Reports Record Fourth Quarter And Full Year 2016 Financial Results 259
  • 6.26 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 261
  • 6.27 Feb 21, 2017: PositiveID Announces 2016 Highlights 264
  • 6.28 Feb 16, 2017: GlucoTrack Maker Presents Scientific Data Demonstrating Reliable Accuracy and Precision 264
  • 6.29 Feb 16, 2017: Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring 265
  • 6.30 Feb 16, 2017: Ascensia Diabetes Care Presents Key Accuracy Data For CONTOUR NEXT ONE BGMS at ATTD 2017 267
  • 6.31 Feb 16, 2017: Ascensia Diabetes Care Presents Key Accuracy Data For CONTOUR PLUS ONE BGMS at ATTD 2017 268
  • 6.32 Feb 15, 2017: Real-World Data From Abbott's Freestyle Libre Show Association Between Higher Frequency Of Glucose Monitoring And Improved Glucose Control For People With Diabetes 268
  • 6.33 Feb 15, 2017: Nemaura Medical to present sugarBEAT Poster at the Advanced Technologies and Treatments for Diabetes Symposium in Paris, February 16th 2017 270
  • 6.34 Feb 15, 2017: Roche Diabetes Care Enters into Agreement with Medtronic 271
  • 6.35 Feb 15, 2017: GluSense Raises USD1.9 Million in Financing Round 271
  • 6.36 Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 271
  • 6.37 Feb 13, 2017: Andon Health Decreases Size of Private Placement of Shares for USD101.6 Million 272
  • 6.38 Feb 09, 2017: Henry Schein Names Bridget A. Ross To Lead Global Medical Group 272
  • 6.39 Feb 09, 2017: Terumo Announces Change of Executive Officers 273
  • 6.40 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 274
  • 6.41 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 283
  • 6.42 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 284
  • 6.43 Feb 06, 2017: GlucoTrack Maker Appoints New Chief Financial Officer 284
  • 6.44 Feb 01, 2017: Roche reports good results in 2016 285
  • 6.45 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 288
  • 6.46 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 289
  • 6.47 Jan 31, 2017: Ascensia Diabetes Care Enters into Agreement with Glooko 290
  • 6.48 Jan 31, 2017: Terumo Opens a Branch in Yangon 291
  • 6.49 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 291
  • 6.50 Jan 30, 2017: Henry Schein Joins Takara Belmont To Support Oral Health Of At-Risk Youth In Israel By Donating State-Of-The-Art Equipment 291
  • 6.51 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 292
  • 6.52 Jan 25, 2017: Novartis Plans to Spin-Off Alcon 293
  • 6.53 Jan 25, 2017: Ypsomed opens a new production line in Solothurn 293
  • 6.54 Jan 24, 2017: Dexcom announces publication of key study in the Journal of the American Medical Association demonstrating the value of CGM in reducing A1C and hypoglycemia in diabetes patients on injection therapy 294
  • 6.55 Jan 24, 2017: Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Tornadoes In The South 295
  • 6.56 Jan 23, 2017: DarioHealth Accelerates US Device Sales and Consumable Strips Growth in Fourth Quarter 296
  • 6.57 Jan 18, 2017: Ascensia Diabetes Care Receives Health Canada License for their CONTOUR® NEXT LINK 2.4 Wireless Blood Glucose Meter as Part of the Medtronic MiniMed 630G System with SmartGuard Technology 296
  • 6.58 Jan 17, 2017: Dr. Carsten Brunn to Lead Bayer's Pharmaceuticals Business in the Americas Region 297
  • 6.59 Jan 12, 2017: Centers for Medicare & Medicaid Services Classify Therapeutic Continuous Glucose Monitors as "Durable Medical Equipment" under Medicare Part B 297
  • 6.60 Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 298
  • 6.61 Jan 11, 2017: The launch of Dexcom Canada will reshape how Canadians living with diabetes access and use continuous glucose monitoring 299
  • 6.62 Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 300
  • 6.63 Jan 09, 2017: OptiScan Biomedical Receives CE Mark for OptiScanner 6000 Automated Device for Monitoring Multiple Key Analytes in ICU Patients 300
  • 6.64 Jan 09, 2017: DarioHealth Raises USD5.1 Million in Venture Financing 302
  • 6.65 Jan 05, 2017: Intuity Medical Raises Additional USD15 Million in Series 3 Financing 302
  • 6.66 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 302

7 Appendix 475

  • 7.1 Methodology 475
  • 7.2 About GlobalData 478
  • 7.3 Contact Us 478
  • 7.4 Disclaimer 478

List of Tables

1.1 List of Tables

  • Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development 25
  • Table 2: Blood Glucose Meters - Pipeline Products by Segment 26
  • Table 3: Blood Glucose Meters - Pipeline Products by Territory 27
  • Table 4: Blood Glucose Meters - Pipeline Products by Regulatory Path 29
  • Table 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date 30
  • Table 6: Blood Glucose Meters - Ongoing Clinical Trials 31
  • Table 7: Blood Glucose Meters Companies - Pipeline Products by Stage of Development 32
  • Table 8: Blood Glucose Meters - Pipeline Products by Stage of Development 37
  • Table 9: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 10: GlucoPEARL - Product Status 42
  • Table 11: GlucoPEARL - Product Description 42
  • Table 12: A. Menarini Diagnostics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 13: GlucoMen Day - Product Status 43
  • Table 14: GlucoMen Day - Product Description 43
  • Table 15: Abbott Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 16: FreeStyle Libre Flash Glucose Monitoring System - Product Status 44
  • Table 17: FreeStyle Libre Flash Glucose Monitoring System - Product Description 45
  • Table 18: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status 45
  • Table 19: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description 46
  • Table 20: Abbott Diabetes Care, Inc. - Ongoing Clinical Trials Overview 47
  • Table 21: FreeStyle Libre Flash Glucose Monitoring System - Accuracy of Flash Glucose Monitoring Freestyle Libre (Abbott) in Home Setting and In-patient Setting During Hypo - Hyperglycemia 48
  • Table 22: FreeStyle Libre Flash Glucose Monitoring System - An Evaluation of Self-management of Diabetes Using FreeStyle Libre Flash Glucose Monitoring System in Young People 48
  • Table 23: FreeStyle Libre Flash Glucose Monitoring System - Frequency of Hypoglycemia in Patients with Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life 48
  • Table 24: FreeStyle Libre Flash Glucose Monitoring System - The Impact on Quality of Life of Novel Glucose -sensing Technology Used by Individuals with Type 2 Diabetes on Intensive-insulin Therapy 49
  • Table 25: Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 26: Continuous Glucose Monitor - Product Status 50
  • Table 27: Continuous Glucose Monitor - Product Description 50
  • Table 28: Advanced Medical Electronics Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 29: Continuous Glucose Monitor - Product Status 51
  • Table 30: Continuous Glucose Monitor - Product Description 51
  • Table 31: AirMarkers Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 32: Diabetes Sensor - Product Status 52
  • Table 33: Diabetes Sensor - Product Description 52
  • Table 34: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 35: Next Generation Glucose Testing Platform System - Version 1 - Product Status 53
  • Table 36: Next Generation Glucose Testing Platform System - Version 1 - Product Description 53
  • Table 37: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Status 54
  • Table 38: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Description 54
  • Table 39: Arkal Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 40: GlucoPod CGM System - Product Status 55
  • Table 41: GlucoPod CGM System - Product Description 55
  • Table 42: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 43: GLUCOCARD X-METER GT-1910 - Product Status 56
  • Table 44: GLUCOCARD X-METER GT-1910 - Product Description 56
  • Table 45: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 46: CONTOUR PLUS ONE - Product Status 57
  • Table 47: CONTOUR PLUS ONE - Product Description 57
  • Table 48: Next Generation Blood Glucose Monitoring System - Product Status 58
  • Table 49: Next Generation Blood Glucose Monitoring System - Product Description 58
  • Table 50: Azurite Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 51: Blood Glucose Sensor - Product Status 59
  • Table 52: Blood Glucose Sensor - Product Description 59
  • Table 53: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 54: Biometric Watch - Product Status 60
  • Table 55: Biometric Watch - Product Description 60
  • Table 56: Baylor University Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 57: Portable Non-Invasive Blood Glucose Monitor - Product Status 61
  • Table 58: Portable Non-Invasive Blood Glucose Monitor - Product Description 61
  • Table 59: Bio-Impedance General Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 60: MD Watch - Product Status 62
  • Table 61: MD Watch - Product Description 62
  • Table 62: Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 63: Non-Invasive Glucose Analyzer - Product Status 63
  • Table 64: Non-Invasive Glucose Analyzer - Product Description 63
  • Table 65: Biorasis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 66: Glucowizzard - Product Status 64
  • Table 67: Glucowizzard - Product Description 64
  • Table 68: BioTelemetry Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 69: Telcare ADMS Trend Monitoring System - Product Status 65
  • Table 70: Telcare ADMS Trend Monitoring System - Product Description 65
  • Table 71: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 72: Smart Tattoo Glucose Sensor - Product Status 66
  • Table 73: Smart Tattoo Glucose Sensor - Product Description 66
  • Table 74: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 75: Multisensor Glucose Monitoring System - Product Status 67
  • Table 76: Multisensor Glucose Monitoring System - Product Description 67
  • Table 77: VSM 3 Glucose Monitoring System - Product Status 68
  • Table 78: VSM 3 Glucose Monitoring System - Product Description 68
  • Table 79: BlueVine Graphene Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 80: Minimally Invasive Glucose Monitoring Device - Product Status 69
  • Table 81: Minimally Invasive Glucose Monitoring Device - Product Description 69
  • Table 82: Noninvasive Glucose Monitoring Device - Product Status 70
  • Table 83: Noninvasive Glucose Monitoring Device - Product Description 70
  • Table 84: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 85: Fluorescence Measurement Device - Product Status 71
  • Table 86: Fluorescence Measurement Device - Product Description 71
  • Table 87: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 88: Glucoband - Product Status 72
  • Table 89: Glucoband - Product Description 72
  • Table 90: Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 91: Non-Invasive Blood Glucose Meter - Product Status 73
  • Table 92: Non-Invasive Blood Glucose Meter - Product Description 73
  • Table 93: Cell MedX Corp Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 94: eBalance Pro Series Device - Product Status 74
  • Table 95: eBalance Pro Series Device - Product Description 74
  • Table 96: Cell MedX Corp - Ongoing Clinical Trials Overview 75
  • Table 97: eBalance Pro Series Device - e-Balance Technology in Modifying Metabolic Pathways in Subjects with Diabetes 76
  • Table 98: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 99: CGM Sensor - Product Status 77
  • Table 100: CGM Sensor - Product Description 77
  • Table 101: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 102: Non-Invasive Glucose Monitor - Product Status 78
  • Table 103: Non-Invasive Glucose Monitor - Product Description 78
  • Table 104: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 105: Wearable Continuous Blood Glucose Monitoring Device - Product Status 79
  • Table 106: Wearable Continuous Blood Glucose Monitoring Device - Product Description 79
  • Table 107: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 108: Closed Loop Continuous Glucose Monitoring System - Product Status 80
  • Table 109: Closed Loop Continuous Glucose Monitoring System - Product Description 80
  • Table 110: Cyber Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 111: Cybersensors Continuous Glucose Sensor - Product Status 81
  • Table 112: Cybersensors Continuous Glucose Sensor - Product Description 81
  • Table 113: DarioHealth Corp Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 114: Dario - Product Status 82
  • Table 115: Dario - Product Description 83
  • Table 116: Next Generation Dario Blood Glucose Monitoring Device - Product Status 83
  • Table 117: Next Generation Dario Blood Glucose Monitoring Device - Product Description 83
  • Table 118: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 119: Integrated iSense CGM And JewelPUMP - Product Status 84
  • Table 120: Integrated iSense CGM And JewelPUMP - Product Description 84
  • Table 121: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 122: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status 85
  • Table 123: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description 86
  • Table 124: Dexcom G5x - Product Status 86
  • Table 125: Dexcom G5x - Product Description 86
  • Table 126: First-Gen Verily Sensor - Product Status 87
  • Table 127: First-Gen Verily Sensor - Product Description 87
  • Table 128: G6 Continuous Glucose Monitor - Product Status 87
  • Table 129: G6 Continuous Glucose Monitor - Product Description 88
  • Table 130: Second-Gen Verily Sensor - Product Status 89
  • Table 131: Second-Gen Verily Sensor - Product Description 89
  • Table 132: DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 133: Infrared Laser Glucometer - Home Use - Product Status 90
  • Table 134: Infrared Laser Glucometer - Home Use - Product Description 90
  • Table 135: Infrared Laser Glucometer - Wearable - Product Status 91
  • Table 136: Infrared Laser Glucometer - Wearable - Product Description 91
  • Table 137: DIRAmed LLC. Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 138: Critical Care Glucose Monitor - Hospital Use - Product Status 92
  • Table 139: Critical Care Glucose Monitor - Hospital Use - Product Description 92
  • Table 140: Glucose Monitor - Home Use - Product Status 93
  • Table 141: Glucose Monitor - Home Use - Product Description 93
  • Table 142: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 143: Continuous Blood Glucose Monitoring System - Product Status 94
  • Table 144: Continuous Blood Glucose Monitoring System - Product Description 94
  • Table 145: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 146: Gen 2 Symphony CGM System - Product Status 95
  • Table 147: Gen 2 Symphony CGM System - Product Description 95
  • Table 148: NextGen System - Product Status 96
  • Table 149: NextGen System - Product Description 96
  • Table 150: Symphony tCGM System - Home - Product Status 96
  • Table 151: Symphony tCGM System - Home - Product Description 97
  • Table 152: Symphony tCGM System - Hospital Critical Care - Product Status 97
  • Table 153: Symphony tCGM System - Hospital Critical Care - Product Description 97
  • Table 154: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 155: Viscosimetric Glucose Sensor - Product Status 98
  • Table 156: Viscosimetric Glucose Sensor - Product Description 98
  • Table 157: eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 158: Optically-Efficient Miniaturized Raman Optical System - Product Status 99
  • Table 159: Optically-Efficient Miniaturized Raman Optical System - Product Description 99
  • Table 160: Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 100
  • Table 161: GSM Enabled Blood Glucose Meter - Product Status 100

List of Figures

1.2 List of Figures

  • Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development 25
  • Figure 2: Blood Glucose Meters - Pipeline Products by Segment 26
  • Figure 3: Blood Glucose Meters - Pipeline Products by Territory 27
  • Figure 4: Blood Glucose Meters - Pipeline Products by Regulatory Path 29
  • Figure 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date 30
  • Figure 6: Blood Glucose Meters - Ongoing Clinical Trials 31
Back to Top